Oswal Yarns (514460)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive book value of ₹8.67 per share gives a small equity base of roughly ₹3.4 crore, providing some asset cushion.
• Losses are modest with ROE at -4.24%, so the existing book value is not being eroded at an alarming pace.
• The trading and distribution model is simple, understandable, and would not require heavy capital expenditure if operations resume.
• The price has already corrected sharply from its 52-week high of ₹38.99 to ₹17.64, removing some speculative froth.

Concerns

• Revenue is effectively zero: the latest quarter shows ₹0 crore sales, and annual sales declined 41.67%.
• Profit growth of -400%, negative ROE/ROCE, and a Piotroski score of 2/9 signal serious financial deterioration.
• At P/B of 2.03, the market capitalisation of ₹7 crore is over twice the book value of roughly ₹3.4 crore—there is no margin of safety.
• Debt/equity, promoter holding, and a credible earnings history are not disclosed, making the microcap financially opaque.

AI Analysis

Let me start by asking a simple question: what does this business earn? The answer is, nothing. Oswal Yarns generated no quarterly sales, sales are down 41.67%, and profit growth is -400%. ROE of -4.24% and ROCE of -1.11% tell me the capital employed in this trading and distribution company is destroying value rather than creating it. A Piotroski score of 2 out of 9 is the kind of red flag I cannot ignore. I look for a moat, but a tiny distributor has no pricing power, no brand, and no durable advantage. On valuation, the picture is worse: the market prices the company at ₹7 crore while book value is only about ₹3.4 crore, so I am being asked to pay 2.03 times book for a business that has stopped selling. The price has fallen from ₹38.99 to ₹17.64, but a falling stock price is not a margin of safety; it is simply Mr. Market changing his mood. There is no dividend, no disclosed promoter holding, and debt/equity is not available, so I cannot verify the balance-sheet risk. Some investors might call this a turnaround or asset play because book value is positive, but Graham taught us to buy only when there is both a reasonable earnings outlook and a clear margin of safety. This fails both tests. It may be a shell waiting for a new business, but I do not invest in hope. I would need to see actual sales resume, credible management, and a price at a meaningful discount to tangible assets before I would give this even a small place in my portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer